Cargando...
Recent advancements of antiangiogenic combination therapies in ovarian cancer
Ovarian cancer is a deadly malignancy with a growing therapeutic armamentarium, though achieving sustained benefit in the clinic remains largely elusive. Through biomarker and genetic analysis, several pathways of resistance and sensitivity to commonly used therapeutics have been identified, expandi...
Guardado en:
| Publicado en: | Cancer Treat Rev |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8217312/ https://ncbi.nlm.nih.gov/pubmed/34051628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2021.102224 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|